Careers
Build what comes next in coronary microvascular medicine.
Lucier is an early-stage biopharmaceutical company translating coronary arteriolar biology into potential medicines for coronary microvascular dysfunction.
General interest
Connect with Lucier
We welcome introductions from scientists, drug-development professionals, and potential collaborators whose experience connects with our work.
Email a brief note about your background and interests along with your resume or CV. Please do not include sensitive personal, medical, or financial information in your initial message.